Company Filing History:
Years Active: 1996
Title: Innovations of Robert T Cass in Thin Film HPMP Matrix Systems
Introduction
Robert T Cass is an accomplished inventor based in San Mateo, CA (US). He holds a patent that showcases his innovative work in the field of thin film hydrophilic polar multi-functionalized polymers (HPMPs). His contributions have significant implications for the construction and display of tethered organic ligand molecules.
Latest Patents
Robert T Cass is credited with a patent titled "Thin film HPMP matrix systems and methods for constructing and." This invention relates to methods and systems that facilitate the unhindered construction and display of tethered organic ligand molecules. The patent describes the preparation and use of thin film, substantially non-crosslinked HPMPs anchored to various functionalized substrates. The HPMP forms a thin film matrix layer that provides a highly hydrated, high dielectric environment equivalent to an aqueous solution, which is essential for the affinity binding of ligands to tagged target molecules.
Career Highlights
Robert T Cass has made significant strides in his career, particularly through his work at Arris Pharmaceutical Corporation. His innovative approach to creating a reusable ligand library has led to a remarkable increase in the sensitivity and speed of screening assays. The HPMP thin film he developed is highly accessible and allows for flexible, three-dimensional display of singly tethered ligands, enhancing the overall efficiency of the binding process.
Collaborations
Robert T Cass has collaborated with notable colleagues, including Derek Hudson and Charles R Johnson. Their combined expertise has contributed to the advancement of technologies in the pharmaceutical field.
Conclusion
Robert T Cass's work in thin film HPMP matrix systems represents a significant advancement in the field of organic ligand binding. His innovative methods and systems have the potential to revolutionize screening assays, making them faster and more sensitive. His contributions continue to impact the pharmaceutical industry positively.